GGrantIndex
← Leaderboards

Donald L Sodora

Seattle Children'S Hospital

Google Scholar ↗PubMed ↗ORCID ↗
$27,419,798
Attributed
$31,426,956
Total exposure
34
Grants
25
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY2005–25
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$31,426,956 · 34

By mechanism

R01$25,854,765 · 9
P51$2,352,740 · 19
R21$1,793,487 · 4
R56$1,425,964 · 2

Top collaborators

Most similar at Seattle Children'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Macaca”

Research focus

MacacaHiv InfectionsImmuneLaboratoriesInfectionMacaca MulattaCellsBloodImmune ResponseLymph NodesPrimatesTransmission ProcessOralDisease ProgressionEventCd4 Positive T LymphocytesRouteImmunologicsDesignMucous MembraneTissuesVirusInflammationBreast Feeding

Grant awards (69)

Rapid disease progression and viral reservoir formation in SIV-infected infant macaques$871,114
R01 · FY2025 · AI · contact PI
Influence of viral and immune interventions on early events following oral SIV infection$797,333
R01 · FY2025 · DE · contact PI
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques$862,669
R01 · FY2024 · AI · contact PI
Influence of viral and immune interventions on early events following oral SIV infection$791,082
R01 · FY2024 · DE · contact PI
Influence of viral and immune interventions on early events following oral SIV infection$957,147
R01 · FY2023 · DE · contact PI
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques$886,371
R01 · FY2023 · AI · contact PI
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques$888,461
R01 · FY2022 · AI · contact PI
Mediators of fatty liver disease during HIV/SIV and cART treatment$879,420
R01 · FY2022 · AI · contact PI
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques$938,584
R01 · FY2021 · AI · contact PI
Mediators of fatty liver disease during HIV/SIV and cART treatment$879,420
R01 · FY2021 · AI · contact PI
Mediators of fatty liver disease during HIV/SIV and cART treatment$873,771
R01 · FY2020 · AI · contact PI
Harnessing oral mucosa vaccination to drive protective HIV antibody responses$718,084
R01 · FY2020 · DE · contact PI
Mediators of fatty liver disease during HIV/SIV and cART treatment$893,138
R01 · FY2019 · AI · contact PI
Harnessing oral mucosa vaccination to drive protective HIV antibody responses$828,617
R01 · FY2019 · DE · contact PI
Impact of Cigarette Smoke on RNA-cap Modifications within HIV Infected Cells$217,060
R21 · FY2019 · DA · contact PI
Mediators of fatty liver disease during HIV/SIV and cART treatment$740,149
R01 · FY2018 · AI · contact PI
Harnessing oral mucosa vaccination to drive protective HIV antibody responses$685,700
R01 · FY2018 · DE · contact PI
Impact of Cigarette Smoke on RNA-cap Modifications within HIV Infected Cells$238,367
R21 · FY2018 · DA · contact PI
Mediators of fatty liver disease during HIV/SIV and cART treatment$200,429
R01 · FY2018 · AI · contact PI
Harnessing oral mucosa vaccination to drive protective HIV antibody responses$170,188
R01 · FY2018 · DE · contact PI
Impact of Cigarette Smoke on RNA-cap Modifications within HIV Infected Cells$52,983
R21 · FY2018 · DA · contact PI
Harnessing oral mucosa vaccination to drive protective HIV antibody responses$855,888
R01 · FY2017 · DE · contact PI
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants$867,023
R01 · FY2016 · DE · contact PI
Harnessing oral mucosa vaccination to drive protective HIV antibody responses$853,346
R01 · FY2016 · DE · contact PI
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants$860,114
R01 · FY2015 · DE · contact PI
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants$872,386
R01 · FY2014 · DE · contact PI
Inhibition of Liver Macrophage activation in SIV infected macaques$237,049
R21 · FY2014 · AI · contact PI
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants$889,528
R01 · FY2013 · DE · contact PI
Identifying, Characterizing and Inducing Effective Anti-HIV T Cell Responses$572,286
R01 · FY2013 · AI · contact PI
Inhibition of Liver Macrophage activation in SIV infected macaques$304,428
R21 · FY2013 · AI · contact PI
Double-Negative T cells in SIV and HIV Infections$630,194
R56 · FY2012 · AI · contact PI
ASSESSMENT OF FORESKIN/PENILE SIV CHALLENGE IN MACAQUES$377,899
P51 · FY2011 · RR · contact PI
FACTORS INFLUENCING ORAL TRANSMISSION OF SIV$302,593
P51 · FY2011 · RR · contact PI
ASSESSMENT OF SIV+ CD4-LOW MANGABEYS$44,598
P51 · FY2011 · RR · contact PI
Dramatic CD4+ T cell depletion without simian AIDS in SIV+ mangabeys$795,770
R56 · FY2010 · AI · contact PI
Factors Influencing Oral Transmission of SIV$752,438
R01 · FY2010 · DE · contact PI
ASSESSMENT OF FORESKIN/PENILE SIV CHALLENGE IN MACAQUES$310,172
P51 · FY2010 · RR · contact PI
FACTORS INFLUENCING ORAL TRANSMISSION OF SIV$99,137
P51 · FY2010 · RR · contact PI
ASSESSMENT OF SIV+ CD4-LOW MANGABEYS$32,896
P51 · FY2010 · RR · contact PI
Factors Influencing Oral Transmission of SIV$737,560
R01 · FY2009 · DE · contact PI
FACTORS INFLUENCING ORAL TRANSMISSION OF SIV$153,315
P51 · FY2009 · RR · contact PI
VIRAL CYTOPATHICITY IN CD4-LOW SIV PASSAGED MANGABEYS$56,690
P51 · FY2009 · RR · contact PI
Factors Influencing Oral Transmission of SIV$758,385
R01 · FY2008 · DE · contact PI
VIRAL CYTOPATHICITY IN CD4-LOW SIV PASSAGED MANGABEYS$67,958
P51 · FY2008 · RR · contact PI
IMMUNE RECONSTITUTION IN SIV INFECTED MACAQUES$67,958
P51 · FY2008 · RR · contact PI
FACTORS INFLUENCING ORAL TRANSMISSION OF SIV$35,843
P51 · FY2008 · RR · contact PI
Factors Influencing Oral Transmission of SIV$760,001
R01 · FY2007 · DE · contact PI
IMMUNE RECONSTITUTION IN SIV INFECTED MACAQUES$65,455
P51 · FY2007 · RR · contact PI
VIRAL CYTOPATHICITY IN CD4-LOW SIV PASSAGED MANGABEYS$52,365
P51 · FY2007 · RR · contact PI
ORAL HIV TRANSMISSION MODEL: RAPID DISSEMINATION OF SIV AFTER ORAL INOCULATION$117,515
P51 · FY2006 · RR · contact PI
Immune reconstitution in SIV infected macaques$548,861
R01 · FY2005 · AI
Viral Cytopathicity in CD4-Low SIV Passaged Mangabeys$275,600
R21 · FY2005 · AI
ORAL HIV TRANSMISSION MODEL: RAPID DISSEMINATION OF SIV AFTER ORAL INOCULATION$155,250
P51 · FY2005 · RR
ANALYSIS OF THYMIC FUNCTION DURING SIV INFECTION$83,814
P51 · FY2005 · RR
Immune reconstitution in SIV infected macaques$28,897
R01 · FY2005 · AI
Immune reconstitution in SIV infected macaques$553,013
R01 · FY2004 · AI
ANALYSIS OF THYMIC FUNCTION DURING SIV INFECTION$82,681
P51 · FY2004 · RR
ORAL TRANSMISSION OF A FLUORESCENT SIV$290,579
R01 · FY2003 · DE
Immune reconstitution in SIV infected macaques$194,802
R01 · FY2003 · AI
ORAL HIV TRANSMISSION MODEL: RAPID DISSEMINATION OF SIV AFTER ORAL INOCULATION$97,817
P51 · FY2003 · RR
ANALYSIS OF THYMIC FUNCTION DURING SIV INFECTION$87,240
P51 · FY2003 · RR
DECREASED THYMIC OUTPUT CORRELATES WITH THYMIC CHANGES IN SIV INFECTED MACAQUES$61,544
P51 · FY2003 · RR
VIROLOGY AND IMMUNOLOGY OF ACUTE HIV1 INFECTION$391,750
R01 · FY2002 · AI
ORAL TRANSMISSION OF A FLUORESCENT SIV$282,434
R01 · FY2002 · DE
QUANTITATIVE ANALYSIS OF CD8 T CELL RESPONSE TO SIV$234,000
R21 · FY2002 · AI
VIROLOGY AND IMMUNOLOGY OF ACUTE HIV1 INFECTION$382,426
R01 · FY2001 · AI
ORAL TRANSMISSION OF A FLUORESCENT SIV$274,525
R01 · FY2001 · DE
QUANTITATIVE ANALYSIS OF CD8 T CELL RESPONSE TO SIV$234,000
R21 · FY2001 · AI
ORAL TRANSMISSION OF A FLUORESCENT SIV$266,846
R01 · FY2000 · DE